Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting.
Shimaa SherifRaghvendra MallHossam AlmeerAdviti NaikAbdulaziz Al HomaidRemy ThomasJessica RoelandsSathiya NarayananMahmoud Gasim MohamedShahinaz BedriSalha Bujassoum Al-BaderKulsoom JunejoDavide BedognettiWouter HendrickxJulie V DecockPublished in: Journal of translational medicine (2022)
We identified an immune-related 3-lncRNA signature with prognostic connotation in multiple solid cancer types which performed equally well and in some cases better than the 20-gene ICR signature, indicating that it could be used as a minimal informative signature for clinical implementation.